Buyer for urological product manufacturer in Europe

Company to buy

• Size: Small to mid-size business
• Revenue: 3 – 30 million EUR
• Target location: Europe
• CFIE PHB257

Overview of buyer for urological product manufacturer in Europe

This pharmaceutical company has carved a niche for itself by specializing in the manufacture of high-quality, innovative pharmaceuticals, OTC products, and food supplements. Recently, the company has experienced exponential growth and now operates extensively across Russia, Belarus, Kazakhstan, Uzbekistan, Ukraine, Azerbaijan, Georgia, and Bulgaria. Crucially, their focus on innovation and quality has allowed them to expand rapidly, becoming a prominent player in the pharmaceutical industry within these regions.

Profile of buyer for urological product manufacturer in Europe

Overall, the company is driven by a mission to provide better access to high-quality, cost-effective pharmaceutical products. In addition, it aims to reduce healthcare expenses and improve global health and well-being. Above all, their vision is to be recognized as a world-class leading pharmaceutical company with a global presence. Collaborating closely with leading scientists, physicians, and pharmaceutical partners, they continually broaden their operational areas. Today, the company ranks among the top ten fastest-growing pharmaceutical firms in these emerging markets, operating in over ten nations and employing more than 500 people.

Activity and products of buyer for urological product manufacturer in Europe

Altogether, the company’s core therapeutic areas include gynecology, neurology, and ophthalmology, with additional involvement in infection and vaccines. In particular, they focus on the discovery, development, and commercialization of prescription medicines, OTC products, and medical devices. Key traditional strengths of the company lie in marketing and promoting quality, innovative pharmaceutical products. Soon, their portfolio is set to double. Yet, they maintain high standards of ethics and responsibility, which are core values for the company. The company’s commitment to innovation is evident in its efforts to register products and commence activities in new markets.

Highlights of buyer for urological product manufacturer in Europe

• Rapid growth and market presence: Operates in over ten nations, with a workforce of more than 500 employees, ranking among the fastest-growing pharmaceutical companies.
• Commitment to innovation: Focuses on the discovery, development, and commercialization of prescription medicines, OTC products, and medical devices across core therapeutic areas.
• Professional development: Continually invests in the training and development of team members to enhance work efficiency and effectiveness.
• Future expansion plans: Aims to register products and commence activities in new markets including the UK, UAE, Romania, Mongolia, Slovakia, Czech Republic, and Slovenia.
• Ethical standards: Maintains high standards of ethics and responsibility, doubling the product portfolio while upholding core values.
• Mission-driven: Dedicated to providing high-quality, cost-effective pharmaceutical solutions to improve global health and well-being.

More information on this buyer for urological product manufacturer in Europe

Please get in touch if you are interested in learning more about this buyer for urological product manufacturer in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.